The upcoming year could be a momentous one for Canadians impacted by rare diseases. In 2019, the Government of Canada committed to developing a National Strategy for Drugs for Rare Diseases, with an initial commitment of $1 billion over two years beginning in 2022-23. This presents a real opportunity for Canadian patients who have struggled to get access to affordable treatment.
Following this month’s Rare Disease Day, join Canada 2020 for an event bringing together industry and government experts and patient advocates to discuss Canada’s rare disease drug strategy and how best to plan for the future.